Home › Funds › Quantum Private Wealth, LLC › TSHA
Quantum Private Wealth, LLC position in TSHA
TAYSHA GENE THERAPIES INC · Health Care
Quantum Private Wealth, LLC reported holding 836,071 shares of TSHA (TAYSHA GENE THERAPIES INC) in its Q3 2026 13F filing — a position valued at US$4.1M, representing 1.04% of its reported portfolio and ranking #21 among its reported holdings. Quantum Private Wealth, LLC has disclosed TSHA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Quantum Private Wealth, LLC's TSHA position evolved
Quantum Private Wealth, LLC first disclosed a stake in TSHA in Q3 2023 at 575,380 shares (US$1.8M). The position peaked in Q2 2026 at 812,027 shares, worth US$5.5M. Across 13 filings, Quantum Private Wealth, LLC increased the stake 9 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 836,071 shares valued at US$4.1M — an increase of 24,044 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 575.38K | $1.82M | New |
| Q4 2023 | 639.52K | $1.13M | Add |
| Q1 2024 | 698.52K | $2.00M | Add |
| Q2 2024 | 730.52K | $1.64M | Add |
| Q3 2024 | 767.62K | $1.54M | Add |
| Q4 2024 | 794.98K | $1.38M | Add |
| Q1 2025 | 791.48K | $1.10M | Hold |
| Q2 2025 | 815.98K | $1.88M | Add |
| Q3 2025 | 822.08K | $2.69M | Add |
| Q4 2025 | 819.72K | $4.51M | Hold |
| Q1 2026 | 849.21K | $3.80M | Add |
| Q2 2026 | 812.03K | $5.53M | Reduce |
| Q3 2026 | 836.07K | $4.07M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TSHA and 13F data
TSHA (TAYSHA GENE THERAPIES INC) is a Health Care company. 49 other funds we track also report a position in TSHA — the largest reported positions include Avoro Capital Advisors LLC (US$162.7M), RA CAPITAL MANAGEMENT, L.P. (US$160.4M), Vestal Point Capital, LP (US$132.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TSHA
- Avoro Capital Advisors LLC 23.89M sh · $162.68M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 23.56M sh · $160.41M · Q2 2026
- Vestal Point Capital, LP 19.41M sh · $132.22M · Q2 2026
- RTW INVESTMENTS, LP 13.56M sh · $92.35M · Q2 2026
- Octagon Capital Advisors LP 9.69M sh · $66.01M · Q2 2026
- Siren, L.L.C. 9.85M sh · $47.95M · Q3 2026
- MPM BioImpact LLC 4.50M sh · $30.64M · Q2 2026
- BAKER BROS. ADVISORS LP 4.00M sh · $27.27M · Q2 2026
- GordonMD Global Investments LP 723.18K sh · $24.50M · Q2 2026
- Casdin Capital 3.25M sh · $22.13M · Q2 2026
- ADAR1 Capital Management, LLC 3.04M sh · $20.71M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 1.99M sh · $13.57M · Q2 2026
More on Quantum Private Wealth, LLC
FAQ
How long has Quantum Private Wealth, LLC held TSHA?
Quantum Private Wealth, LLC has disclosed TSHA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Quantum Private Wealth, LLC's current position in TSHA?
As of Q3 2026, Quantum Private Wealth, LLC holds 836.07K shares of TSHA (TAYSHA GENE THERAPIES INC), valued at $4.07M, representing 1.04% of its reported portfolio and ranking #21.
Has Quantum Private Wealth, LLC been buying or selling TSHA?
In the latest 13F filing (Q3 2026), Quantum Private Wealth, LLC increased its position in TSHA. The position peaked in Q2 2026 at 812.03K shares.
Which other funds hold TSHA?
Other major institutional holders of TSHA include Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.